Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision stamp was updated to v3.6.4, replacing the previous v3.6.3. This indicates an incremental update to the website's codebase.
    Difference
    0.0%
    Check dated 2026-07-28T14:12:17.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.0 to v3.6.3, indicating a minor system update; no changes to the study details are reflected.
    Difference
    0.0%
    Check dated 2026-06-30T01:31:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study page now shows that enrollment has ended and adds helpful sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and records a version bump from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T17:14:02.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, updating the site version from v3.5.4. This reflects a general platform update applied to the page footer.
    Difference
    0.0%
    Check dated 2026-06-08T16:20:07.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer revision of the page metadata associated with an updated release of the document.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:40.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    In the Taiwan locations list, the Taoyuan District entry was removed and replaced with Taoyuan, Taiwan, 333, preserving the same site code. This reflects a standardization of the city name in the study's locations.
    Difference
    0.0%
    Check dated 2026-05-03T19:36:49.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.